Taking people in EgyptNo phase
Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura
Key facts
- Where
- Sohag, EgyptSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT07093606, who can take part
Where in Egypt
- Sohag University HospitalSohag, EgyptContact: Magdy M Amin, ProfessorTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Sohag University
- Trial code
- NCT07093606
- Record updated
- 30 July 2025
- Original description
this study amis to assess the incidence and severity of liver dysfunction in ITP patients receiving eltrombopag.Read full original descriptionShow less
this study amis to assess the incidence and severity of liver dysfunction in ITP patients receiving eltrombopag.
Exclusion: Pre-existing liver disease (e.g., hepatitis, cirrhosis, NAFLD). Concurrent use of hepatotoxic drugs. Patients lost to follow-up.